PUBLISHER: Lucintel | PRODUCT CODE: 1418356
PUBLISHER: Lucintel | PRODUCT CODE: 1418356
Remdesivir Trends and Forecast
The future of the global remdesivir market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets. The global remdesivir market is expected to grow with a CAGR of 7.0% from 2024 to 2030. The major drivers for this market are growing cases of viral infections and rise in unhygienic practices in rural areas, and rise in the need for prevention of viral infections.
A more than 150-page report is developed to help in your business decisions.
Remdesivir by Segment
The study includes a forecast for the global remdesivir by dosage, form, application, distribution channel , and region.
List of Remdesivir Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies remdesivir companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the remdesivir companies profiled in this report include-
Remdesivir Market Insights
Lucintel forecasts that 100MG will remain the largest segment over the forecast period due to inhibiting the replication of the SARS-cov-2 virus.
Within this market, hospital pharmacy will remain the largest segment due to prescription-only medication.
North America will remain the largest region over the forecast period due to the high prevalence of COVID-19.
Features of the Global Remdesivir Market
Market Size Estimates: Remdesivir market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Remdesivir market size by various segments, such as by dosage, form, application, distribution channel , and region in terms of value ($B).
Regional Analysis: Remdesivir market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different dosage, form, application, distribution channel , and regions for the remdesivir market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the remdesivir market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the growth forecast for remdesivir market?
Answer: The global remdesivir market is expected to grow with a CAGR of 7.0% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the remdesivir market?
Answer: The major drivers for this market are growing cases of viral infections and rise in unhygienic practices in rural areas, and rise in the need for prevention of viral infections.
Q3. What are the major segments for remdesivir market?
Answer: The future of the remdesivir market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets.
Q4. Who are the key remdesivir market companies?
Answer: Some of the key remdesivir companies are as follows.
Q5. Which remdesivir market segment will be the largest in future?
Answer: Lucintel forecasts that 100MG will remain the largest segment over the forecast period due to inhibiting the replication of the SARS-cov-2 virus.
Q6. In remdesivir market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to the high prevalence of COVID-19.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.